This article presents a unique method for analyzing host-microbiome interactions using a novel gut organ culture system for ex vivo experiments.
The structure of the gut tissue facilitates close and mutualistic interactions between the host and the gut microbiota. These cross-talks are crucial for maintaining local and systemic homeostasis; changes to gut microbiota composition (dysbiosis) associate with a wide array of human diseases. Methods for dissecting host-microbiota interactions encompass an inherent tradeoff among preservation of physiological tissue structure (when using in vivo animal models) and the level of control over the experiment factors (as in simple in vitro cell culture systems). To address this tradeoff, Yissachar et al. recently developed an intestinal organ culture system. The system preserves a naive colon tissue construction and cellular mechanisms and it also permits tight experimental control, facilitating experimentations that cannot be readily performed in vivo. It is optimal for dissecting short-term responses of various gut components (such as epithelial, immunological and neuronal elements) to luminal perturbations (including anaerobic or aerobic microbes, whole microbiota samples from mice or humans, drugs and metabolites). Here, we present a detailed description of an optimized protocol for organ culture of multiple gut fragments using a custom-made gut culture device. Host responses to luminal perturbations can be visualized by immunofluorescence staining of tissue sections or whole-mount tissue fragments, fluorescence in-situ hybridization (FISH), or time-lapse imaging. This system supports a wide array of readouts, including next-generation sequencing, flow cytometry, and various cellular and biochemical assays. Overall, this three-dimensional organ culture system supports the culture of large, intact intestinal tissues and has broad applications for high-resolution analysis and visualization of host-microbiota interactions in the local gut environment.
The intestine is a highly complex organ containing a wide range of cell types (epithelial cells, immune system cells, neurons, and more) organized in a particular structure that allows cells to interact and communicate with one another and with the luminal content (microbiota, food, etc.)1. Currently, the research toolbox available for analyzing host-microbiota interactions includes in vitro cell cultures and in vivo animal models2. In vivo animal models provide a physiological tissue construction3 but with poor experimental control and limited ability to manipulate the experiment conditions. In vitro culture systems, on the other hand, use primary cells or cell lines that can be supplemented with microbes4, offering tight control over the experiment parameters but lack the cellular complexity and the tissue architecture. Modern in vitro assays allow the advanced use of healthy and pathological human tissue samples, like epithelial organoids derived from mouse or human sources5,6, and samples that mimic the mucosal microenvironment7. Another example is the 'gut on a chip' assay, which includes the human colonic epithelial cell line (Caco2), extracellular matrix and microfluidic channels to mimic the physiological condition of the gut invariant8. However, as advanced and innovative as in vitro samples may be, they do not maintain a normal tissue architecture or naïve cellular composition.
To address that, Yissachar et al. recently developed an ex vivo organ culture system9 (Figure 1) that maintains intact gut fragments ex vivo, benefiting from the advantages of both in vivo and in vitro models. This ex vivo gut organ culture system is based on a custom-made culture device that supports a multiplexed culture of six colon tissues, allowing examining experimental inputs under comparable conditions while controlling the system's inputs and outputs. Recent works have demonstrated that this system is valuable for analyzing intestinal responses to individual gut bacteria9, whole human microbiota samples10 and microbial metabolites11. This system allows, for the first time, the study of these early host-microbiota interactions with a high level of control over the host, microbial and environmental components. Furthermore, it allows monitoring and manipulating the system throughout the experiment, in real-time.
Figure 1: Schematics of the gut culture device. A whole intestinal tissue fragment is attached to the output and input ports of the chamber (top), with pumps regulating the medium flow inside the lumen and in the external medium chamber. The entire device (bottom) contains 6 such chambers. This figure has been modified from Yissachar et al. 2017. Please click here to view a larger version of this figure.
This protocol follows the animal care guidelines approved by the ethics committee for animal welfare.
1. Experiment preparation
2. Experiment setup preparation
3. Organ cultures
The gut organ culture system maintains tissue viability ex vivo. The evaluation of the tissue viability was done throughout the culture period. Colon tissue fragments were incubated in the gut organ culture system and fixed following 2/12/24 h culture. The intestinal epithelial cell (IEC) layer integrity was validated by immunofluorescence staining using E-cadherin and cytokeratin-18 antibodies. Likewise, mucus-filled goblet cells in the colonic epithelium and mucus secretion within the lumen were detected as well as proliferating IEC in the colonic crypts, as indicated by Ki-67 staining (Figure 2). These results and others9 show that the gut culture system maintain intestinal function and structure ex vivo.
Rapid transcriptional host response was triggered by intestinal colonization with segmented filamentous bacteria (SFB). Colonization by two different immunomodulating gut microbes were used to examine the initial events induced in the gut. The primary microbe was segmented filamentous bacteria (SFB) that was previously shown to induce differentiation of Th17 cell in the small intestine13. SFB-negative SPF mice were sacrificed and segments of the small intestine (SI) (ileum) were dissected and connected to the gut organ culture system. As SFB is difficult to culture in vitro14, organ cultures were infused with a suspension of fecal pellets from SFB monocolonized mice15 or fecal pellets from GF mice as control. SFB induced Th17 through adherence to the intestinal epithelium13,16. Thus, the evaluation of the spatial localization of SFB early after ex vivo colonization of intestinal tissue was required. As shown in (Figure 3a), typical SFB filaments were detected in close association with the SI villi using fluorescence in situ hybridization (FISH), 2 h after SFB introduction. Additionally, a transmission electron microscopy presented SFB within a few microns of the SI epithelium brush border (Figure 3b). At that point, Yissachar et al. examined whether the primary association of SFB with the small intestine epithelium activated a transcriptional response in the tissue. Gene expression profiles of whole-tissue samples were produced, in triplicate, 2 h after infusion with SFB. Control cultures were infused with fecal suspensions of GF or B.fragilis-monocolonized mice (as a non-Th17-inducing control). Figure 3c shows that the changes persuaded by SFB were mainly of small amplitude, compared to the GF control.
Figure 2: The gut organ culture system maintains tissue viability ex vivo. Immunofluorescence staining of Mucin-2 and Cytokeratin-18 (top), E-cadherin (middle) and Ki-67 (bottom). Confocal imaging of freshly dissected colon tissues and tissues cultured for 2/12/24 h in the gut organ culture device. Scale bar, 40 mm. This figure has been modified from Yissachar et al. 2017. Please click here to view a larger version of this figure.
Figure 3: Mucosal association and rapid transcriptional triggering of a typical signature by SFB. (A, B) SFB associates with the intestinal epithelium after 2 h in cultured small intestine segment visualized by (A) FISH with an SFB-specific probe (red) or (B) electron microscopy. (C) Induction of intestinal gene expression by SFB. SI organ cultures were infused with microbes containing supernatant of feces from SFB monocolonized mice or GF controls and cultured for 2 h before microarray profiling of gene expression in the entire tissue. Modifications in gene expression on a ''volcano plot'' comparing SFB or GF infused cultures. Transcripts up or down-regulated by SFB in whole SI in vivo are highlighted (red and blue, respectively). This figure has been modified from Yissachar et al. 2017. Please click here to view a larger version of this figure.
This article describe an optimized protocol for ex vivo gut organ cultures that Yissachar et al. have recently developed (published9 and unpublished data). The gut organ culture system supports multiplexed culture of intact intestinal fragments while maintaining luminal flow. It provides full control over the intra- and extra-luminal environment (including stimulation dose, exposure time and flow rate) and preserves the naïve intestinal tissue structure and its cellular complexity9.
Critical steps in the protocol include the following. (1) Tissue dissection should be performed in minimal time, and very gently, to minimize tissue damage (which may lead to cell death and leaking of luminal content through damaged sites). (2) Maintain tissue orientation in the device by connecting the input port to the proximal colon, and the output port to the distal end of the colon. (3) After connecting the gut to the device, make sure that the tissue is intact and that the connection points to the intra-luminal ports are not leaking. That will keep the bacterial stimulation inside the lumen and will not contaminate the external environment, which should be maintained as sterile as possible. (4) Tissues should be dissected from mice aged 12-14 days. In younger mice, the colon is smaller and gentler and requires different handling and culture conditions (data not shown). Tissues from older mice are significantly larger, which affects tissue viability and culture duration. (5) To reduce variability in gut responses, use tissues dissected from littermate mice in each device (reduce variability in endogenous microbiome composition, similar to in vivo experimental design).
Current limitations of the gut culture system include the following. (1) Each device contains six channels, which limit the number of different conditions that can be tested in one experiment. (2) Tissues should be dissected from mice aged 12-14 days (see above); thus, the enteric immune system and the epithelial barrier have not reached final maturation. (3) Tissue viability in culture is impaired if culture duration exceeds 24 h (for colon tissues, less for small intestine). (4) This protocol requires the purchase of special equipment (i.e., syringe pumps, custom-made incubator, and others).
In summary, the gut organ culture system serves as an intermediate experimental step between simple in vitro assays to complex in vivo experiments. It offers a combination of high controllability (as in simple in vitro assays) with preservation of intestinal physiology (closely resembles in vivo models) – a significant and unique advantage of this system. This advantage facilitates experimentations that cannot be readily performed in mice (i.e., tracking early responses of gut-residing cells in high temporal resolution). Recently, it has enabled us to discover some surprising connections between the gut microbiome (specific microbes and whole human-derived microbiota) and the intestinal immune and nervous systems9,10. Overall, this powerful and unique tool can be combined with a wide range of readout techniques (including next-generation sequencing, imaging, cell sorting, and more) and provides some novel insights into host-microbiome interactions in health and disease.
The authors have nothing to disclose.
We thank past and present members of the Yissachar lab for their valuable contributions in optimizing the gut organ culture system protocol. We thank Yael Laure for critical editing of the manuscript. This work was supported by the Israel Science Foundation (grant No. 3114831), the Israel Science Foundation – Broad Institute Joint Program (grant No. 8165162), and the Gassner Fund for Medical Research, Israel.
Device | |||
18 Gauge Blunt Needle | Mcmaster | 75165a754 | |
22 Gauge Blunt Needle | Mcmaster | 75165a758 | |
All Purpose Adhesive Selant 100% Silicone | DAP | 688 | |
Cubic Vacuum Desiccator VDC-21+ 2 Shelves | AAAD4021 | ||
Glass Slide 1 mm Thick | Corning | 2947-75X50 | |
Mini Incubator im-10 | AAH24315K | ||
MPC 301E Vacuum PUMP | VI-412711 | ||
Plastic Quick Turn Tube Coupling Plugs | Mcmaster | 51525k121 | |
plastic Quick Turn Tube Coupling Sockets | Mcmaster | 52525k211 | |
Sylgard 184 Silicone Elastomer | Dow | Polydimethylsiloxane, PDMS | |
Tubing | Mcmaster | 6516t11 | |
Zortrax M200 | Zortrax | Zortrax Z-SUITE, Autodesk Fusion 360 | |
Zortrax M200 Materials: z-ultrat | Zortrax | ||
Medium | |||
B27 Supplement (50x), Serum Free | Thermo Fisher Scientific | 17504044 | |
HEPES Buffer (1M) | Thermo Fisher Scientific | 15630056 | |
Iscove's Mod Dulbecco's Medium With Phenol Red (1x) | Thermo Fisher Scientific | 12440061 | |
Knock-Out Serum | Thermo Fisher Scientific | 10828028 | |
N2 Supplement (100x) | Thermo Fisher Scientific | A1370701 | |
Non Essential Amino Acid (100x) | Thermo Fisher Scientific | 11140035 | |
Surgical Tools | |||
Large Scissors | Aseltech | 11-00-10 | |
Sharp Forceps | F.S.T | 11297-10 | |
Silk Braided Surgical Thread | SMI | 8010G | |
Straight Scissors | F.S.T | 14091-09 | |
Thin Forceps | F.S.T | 11051-10 | |
Organ System | |||
0.1 µm Filter | Life Gene | ||
0.22 µm Filter | Life Gene | ||
5 mL Luer Lock Syringe | B-D | 309649 | |
Greenough Stereo Microscope | ZEISS | Stemi 305 | |
Recirculating Precision Air Heater "CUBE" | CUBE-2-LIS | ||
Syringe Pump | new era pump systems inc | nep-ne-1600-em |